Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 3
1984 8
1985 3
1986 6
1987 16
1988 5
1989 3
1990 2
1991 6
1992 1
1993 5
1994 8
1995 8
1996 5
1997 7
1998 3
1999 8
2000 11
2001 8
2002 7
2003 8
2004 3
2005 5
2007 5
2008 3
2009 2
2010 5
2011 7
2012 5
2013 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
Bhatia S, Davies SM, Scott Baker K, Pulsipher MA, Hansen JA. Bhatia S, et al. Biol Blood Marrow Transplant. 2011 Oct;17(10):1428-35. doi: 10.1016/j.bbmt.2011.07.005. Epub 2011 Jul 18. Biol Blood Marrow Transplant. 2011. PMID: 21763253 Free PMC article. Review.
Solid cancers after bone marrow transplantation.
Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland JC, Parker PA, Snyder DS, Spielberger R, Stein A, Forman SJ. Bhatia S, et al. J Clin Oncol. 2001 Jan 15;19(2):464-71. doi: 10.1200/JCO.2001.19.2.464. J Clin Oncol. 2001. PMID: 11208840
Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.
Nademanee A, Molina A, O'Donnell MR, Dagis A, Snyder DS, Parker P, Stein A, Smith E, Planás I, Kashyap A, Spielberger R, Fung H, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Blume KG, Niland J, Forman SJ. Nademanee A, et al. Blood. 1997 Nov 15;90(10):3844-52. Blood. 1997. PMID: 9354650 Free article. Clinical Trial.
165 results